Zeus, Inc. Company Profile

19:23 EST 23rd November 2017 | BioPortfolio

News Articles [11 Associated News Articles listed on BioPortfolio]

Arcis completes second round of fundraising

Corporate finance adviser Zeus Capital advised the company on the funding round from existing shareholders and a new network of private investors. Arcis completed a first fundraising round in December...

ZEUS Scientific Announces U.S. FDA Premarket Approvals (PMA) and Launch of its ZEUS ELISA™ Parvovirus B19 Test Systems

Designed to significantly improve laboratory’s processing turnaround time and productivity with excellent precision and accuracy Branchburg, NJ, USA (PRWEB) September 22, 2017 ZEUS Scientific, a le...

Zeus Industrial Products, Inc. Sub-Lite-Wall StreamLiner XT Allows For Greater Access In Catheter Design

  Life Sciences Jobs   ...

C4X raises £5m to advance drugs pipeline

Manchester-based drug discovery and development company C4X Discovery has raised £5m through a share placing as it seeks to progress its existing "innovative pipeline towards the clinic". The ...

Doc Doc Zeus: A Glimpse Behind the Scenes of Medical Boards

A novel about a doctor who raped a minor and is being investigated by his state medical board provides behind-the-scene insights into the workings of medical boards. It helps explain why these boards ...

Advancing Bioabsorbable Scaffolds with Polymer Technology

TORONTO, ON--(Marketwired - September 05, 2017) - In an Xtalks webinar coming up on Thursday, September 14, 2017, at 10 am CST/China (UTC/GMT+8), learn how next generation bioabsorbable vascular scaff...

Zavante Therapeutics To Present ZOLYD™ Data From Pivotal ZEUS Study At ID Week 2017

SAN DIEGO, Sept. 20, 2017 /PRNewswire/ -- Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, and its r...

Zavante Therapeutics Presents Additional Clinical And Microbiologic Data From ZOLYD™ Phase 2/3 Trial At ID Week 2017

SAN DIEGO, Oct. 4, 2017 /PRNewswire/ -- Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, is presenti...

Drugs and Medications [0 Results]


PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Robotic Surgery: Fast Forward to Telemedicine.

Since the realization that certain maladies can be corrected via surgical techniques, we have been consumed by the desire to constantly advance the tools of surgery, as well as the techniques. In rece...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

The objective of this study is to evaluate the efficacy and safety of gemigliptin 50 mg orally administered once daily for 24 weeks compared with placebo in patients with type 2 diabetes m...

Companies [3 Associated Companies listed on BioPortfolio]

Zeus Industrial Products, Inc.

ZEUS. Solutions In a world dominated by commodity products, it isn’t easy to find suppliers willing and able to take on challenging assignments. Yet in a business environment where competitiveness ...

Zeus Technology Ltd.

Founded in 1996, we develop application traffic management software. This means that we dramatically improve network and web-enabled applications and services making them run faster, more reliable, mo...

Zeus, Inc.

More Information about "Zeus, Inc." on BioPortfolio

We have published hundreds of Zeus, Inc. news stories on BioPortfolio along with dozens of Zeus, Inc. Clinical Trials and PubMed Articles about Zeus, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zeus, Inc. Companies in our database. You can also find out about relevant Zeus, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record